Bayer Kogenate FS
Bayer HealthCare, Biological Products Division

Contact Search Press Sitemap  
HomePatients & CaregiversHealthcare ProfessionalsPrescribing Information
Prescribing Information
Important Safety Information
Administration
HCP Video
Product Benefits
Hemophilia Awards
EZ-Log
EZ-Log Handheld
EZ-Log Web Client
Clinic Support
Bayer Factor Solutions
Rep Finder
Summer Camps
Patient Education Materials
HCP Resources
HCP FAQ
Bayer Links
Bayer Global
Living with Hemophilia
   General Conditions of Use
Privacy Statement
Imprint
  
 
  

Tracking treatment is essential for optimal management of hemophilia A. EZ-Log is setting the standard in electronic treatment tracking and reporting, with diary options that provide flexibility, accuracy, convenience, and security—for patients, caregivers, and healthcare professionals.

Choose your electronic diary option

The EZ-Log Handheld Device

The EZ-Log handheld device is free for Kogenate® FS patients and ideal for patients and caregivers on-the-go—record treatment anywhere and transmit data using the EZ-Log Bluetooth modem or over the Internet by linking the EZ-Log handheld device to your computer.

NEW Web Client Internet Site*

EZ-Log Web Client is free for all patients with hemophilia and provides the option for patients to log treatment information on the secure EZ-Log Website wherever Internet access is available. Enter and transmit data with a simple mouse click.

*A computer and Internet connection are required.

Patient Data Recorded Using EZ-Log is Private and Secure

  • Privacy is protected with a secure personal ID number and password
  • Data transmission to and from EZ-Log server is encrypted
  • Data is stored in a secure data center with systems and protocols in place to address standards for HIPAA
  Terms & Conditions

For more information on the EZ-Log handheld device and the Web Client Internet site or how to enroll, contact your Bayer HealthCare representative or the EZ-Log Support Desk at 800-732-4188 x27 or at support@aheh.com.

 

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.